Daniel Billen
Chairman presso AURINIA PHARMACEUTICALS INC.
Patrimonio netto: 167 299 $ in data 31/03/2024
Profilo
Daniel G.
Billen's current job is Chairman at Aurinia Pharmaceuticals, Inc. His former jobs include Vice President & General Manager at Amgen, Inc., General Manager at Amgen Canada, Inc., and Head-Marketing & Sales at Janssen, Inc. He holds a doctorate degree from Université Catholique de Louvain.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 23/05/2023 | 33 393 ( 0.02% ) | 167 299 $ | 31/03/2024 |
Posizioni attive di Daniel Billen
| Società | Posizione | Inizio |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Chairman | 18/08/2023 |
Precedenti posizioni note di Daniel Billen
| Società | Posizione | Fine |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | 01/01/2018 |
Amgen Canada, Inc.
 Amgen Canada, Inc. BiotechnologyHealth Technology Amgen Canada, Inc. operates as a biotechnology company. The company was founded in 1991 and is headquartered in Mississauga, Canada. | Corporate Officer/Principal | 01/01/2011 |
Janssen, Inc.
 Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada. | Sales & Marketing | 01/01/1991 |
Formazione di Daniel Billen
| Université Catholique de Louvain | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| AURINIA PHARMACEUTICALS INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Amgen Canada, Inc.
Amgen Canada, Inc. BiotechnologyHealth Technology Amgen Canada, Inc. operates as a biotechnology company. The company was founded in 1991 and is headquartered in Mississauga, Canada. | Health Technology |
Janssen, Inc.
Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada. | Health Technology |
- Borsa valori
- Insiders
- Daniel Billen
